Yu-liang TAN ; James Q YIN
Acta Pharmaceutica Sinica 2005;40(3):193-198
Animals ; Gene Expression Regulation, Neoplastic ; Gene Silencing ; Gene Targeting ; Genes, Tumor Suppressor ; Genetic Therapy ; Humans ; Neoplasms ; therapy ; Neovascularization, Pathologic ; genetics ; Proto-Oncogenes ; genetics ; RNA Interference ; RNA, Small Interfering ; genetics ; therapeutic use